NO20073176L - Nye medikamenter for behandling av luftveissykdommer - Google Patents

Nye medikamenter for behandling av luftveissykdommer

Info

Publication number
NO20073176L
NO20073176L NO20073176A NO20073176A NO20073176L NO 20073176 L NO20073176 L NO 20073176L NO 20073176 A NO20073176 A NO 20073176A NO 20073176 A NO20073176 A NO 20073176A NO 20073176 L NO20073176 L NO 20073176L
Authority
NO
Norway
Prior art keywords
treatment
respiratory diseases
new drugs
compounds
formula
Prior art date
Application number
NO20073176A
Other languages
English (en)
Inventor
Andreas Schnapp
Ingo Konetzki
Thierry Bouyssou
Philipp Lustenberger
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20073176L publication Critical patent/NO20073176L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Anvendelsen av forbindelser med den generelle Formel 1, hvor restene R1, R2 og R3 kan ha de betydninger som er nevnt i kravene og i beskrivelsen, for fremstilling av et medikament til behandling av luftveissykdommer, samt nye forbindelser med Formel 1, fremgangsmåter for fremstilling av disse og farmasøytiske formuleringer som inneholder disse, beskrives.
NO20073176A 2005-02-24 2007-06-22 Nye medikamenter for behandling av luftveissykdommer NO20073176L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005008921A DE102005008921A1 (de) 2005-02-24 2005-02-24 Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
PCT/EP2006/060033 WO2006089859A1 (de) 2005-02-24 2006-02-16 Neue arzneimittel zur behandlung von atemwegserkrankungen

Publications (1)

Publication Number Publication Date
NO20073176L true NO20073176L (no) 2007-09-17

Family

ID=36179764

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073176A NO20073176L (no) 2005-02-24 2007-06-22 Nye medikamenter for behandling av luftveissykdommer

Country Status (26)

Country Link
US (3) US20060189605A1 (no)
EP (1) EP1856070B1 (no)
JP (1) JP4950075B2 (no)
KR (1) KR20070110386A (no)
CN (1) CN101128444A (no)
AR (1) AR055562A1 (no)
AT (1) ATE517877T1 (no)
AU (1) AU2006218010B2 (no)
BR (1) BRPI0607258A2 (no)
CA (1) CA2598914A1 (no)
DE (1) DE102005008921A1 (no)
DK (1) DK1856070T3 (no)
EA (1) EA012439B1 (no)
ES (1) ES2370653T3 (no)
IL (1) IL185444A0 (no)
MX (1) MX2007010363A (no)
MY (1) MY146802A (no)
NO (1) NO20073176L (no)
NZ (1) NZ561743A (no)
PE (1) PE20061097A1 (no)
PL (1) PL1856070T3 (no)
TW (1) TWI369988B (no)
UA (1) UA90504C2 (no)
UY (1) UY29394A1 (no)
WO (1) WO2006089859A1 (no)
ZA (1) ZA200704727B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005008921A1 (de) * 2005-02-24 2006-08-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
US7423146B2 (en) 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
PE20080610A1 (es) * 2006-08-22 2008-07-15 Boehringer Ingelheim Int Nuevos beta-agonistas enantiomericamente puros, procedimientos para su preparacion y uso como medicamentos
UY30552A1 (es) * 2006-08-22 2008-03-31 Boehringer Ingelheim Int Combinaciones farmacologiicas en base a derivados sustituidos de la n-(5-{2-[1,1-dimetil-propilamino]-1-hidroxi-metil}-2-hidroxi-fenil)-metansulfonamida y aplicaciones
EP2056836A1 (en) * 2006-08-22 2009-05-13 Boehringer Ingelheim International GmbH Powder formulations for inhalation containing enantiomerically pure beta-agonists
PE20080425A1 (es) * 2006-08-22 2008-06-16 Boehringer Ingelheim Int Formulacion aerosol para la inhalacion de beta-agonistas
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
GB201217330D0 (en) * 2012-09-28 2012-11-14 Univ Cardiff Therapeutic for treating inflammatory lung disorders
WO2016103176A1 (en) 2014-12-24 2016-06-30 Kither Biotech S.R.L. Novel pi3k gamma inhibitor peptide for treatment of respiratory system diseases

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3026534A1 (de) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
DE3609152A1 (de) * 1986-03-19 1987-09-24 Bayer Ag Verfahren zur herstellung des (-)-antipoden des (e)-1-cyclohexyl-4,4-dimethyl- 3-hydroxy-2-(1,2,4-triazol-1-yl)-pent-1-ens
AU2004226824B2 (en) * 2003-04-04 2008-05-01 Novartis Ag Quinoline-2-one-derivatives for the treatment of airways diseases
DE102004003428A1 (de) * 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102005008921A1 (de) * 2005-02-24 2006-08-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
US7423146B2 (en) * 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
UY30552A1 (es) * 2006-08-22 2008-03-31 Boehringer Ingelheim Int Combinaciones farmacologiicas en base a derivados sustituidos de la n-(5-{2-[1,1-dimetil-propilamino]-1-hidroxi-metil}-2-hidroxi-fenil)-metansulfonamida y aplicaciones
PE20080425A1 (es) * 2006-08-22 2008-06-16 Boehringer Ingelheim Int Formulacion aerosol para la inhalacion de beta-agonistas

Also Published As

Publication number Publication date
AU2006218010B2 (en) 2013-02-14
EP1856070A1 (de) 2007-11-21
ES2370653T3 (es) 2011-12-21
IL185444A0 (en) 2008-01-06
US20110053926A1 (en) 2011-03-03
PE20061097A1 (es) 2006-11-14
WO2006089859A1 (de) 2006-08-31
MX2007010363A (es) 2007-09-25
EA200701615A1 (ru) 2008-02-28
EA012439B1 (ru) 2009-10-30
KR20070110386A (ko) 2007-11-16
AU2006218010A1 (en) 2006-08-31
TWI369988B (en) 2012-08-11
CN101128444A (zh) 2008-02-20
ATE517877T1 (de) 2011-08-15
CA2598914A1 (en) 2006-08-31
NZ561743A (en) 2009-09-25
PL1856070T3 (pl) 2011-12-30
EP1856070B1 (de) 2011-07-27
MY146802A (en) 2012-09-28
US20090105236A1 (en) 2009-04-23
UA90504C2 (ru) 2010-05-11
JP2008531518A (ja) 2008-08-14
DE102005008921A1 (de) 2006-08-31
JP4950075B2 (ja) 2012-06-13
TW200640465A (en) 2006-12-01
DK1856070T3 (da) 2011-09-26
BRPI0607258A2 (pt) 2009-08-25
UY29394A1 (es) 2006-10-02
AR055562A1 (es) 2007-08-22
ZA200704727B (en) 2008-09-25
US20060189605A1 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
NO20052883L (no) Nye medikamenter for behandling av kronisk obstruktiv luftveissykdom.
NO20061151L (no) Succinat- og malonatsalt av trans-4-((ir,3s)-6-klor-3-fenylindan-i-yl)-1,2,2-trimetylpiperazin og anvendelsen som et medikament
TW200621762A (en) Novel compounds
NO20062335L (no) Nye diazaspiroalkaner og deres anvendelse i behandlingen av CCR8 medierte sykdommer
MX2008013836A (es) Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos.
NO20070576L (no) Nye hydantionderivater for behandling av obstruktive luftveissykdommer.
NO20074703L (no) Antibakterielle piperidinderivater
NO20080164L (no) N-(pyridin-2-yl)-sulfonamidderivater
NO20092723L (no) Indazolylester og amidderivater for behandling av gluccocorticoid reseptormedierte sykdommer
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
NO20065060L (no) Farmasoytiske kombinasjoner inneholdende benzoksazin for behandling av respiratoriske forstyrrelser
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
MY145647A (en) (4-hydroxy-2-oxo-3h-benzothiazol-7-yl)ethylamine derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy (for example in the treatment of respiratory disease states)
NO20064078L (no) Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter
TW200626553A (en) Novel compounds
WO2006096444A3 (en) Chemical compounds
NO20043792L (no) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
TW200639156A (en) New compounds
NO20083790L (no) Nye terapeutiske kombinasjoner for behandling eller forebygging av psykotiske lidelser
DE602005018634D1 (de) Substituierte n-arylbenzamide und verwandte verbindungen zur behandlung von amyloidkrankheiten und synukleinopathien
NO20053809L (no) Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
NO20090067L (no) Farmasoytiske kombinasjoner for behandling av respiratoriske sykdommer
EA200701615A1 (ru) Новые лекарственные средства для лечения заболеваний дыхательных путей
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
NO20054168L (no) Substituerte 3-(benzoylureido)-tiofenderivater, fremgangsmate for fremstilling og anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application